Skip to main content
Caplight Logo









Guangzhou Weimi Bio-Tech Co., Ltd.

Guangzhou Weimi Bio-Tech Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttps://www.weimibio.cn/

Last Round

Series B

Oct 1, 2021

Total Funding Raised

$15.5M

Company Overview

Guangzhou Weimi Bio-Tech Co., Ltd. is a biotechnology company that develops, manufactures, and distributes in vitro diagnostic (IVD) products and point-of-care testing solutions for medical practitioners.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

in vitro diagnosticIVDdiagnostic analyzertest reagentschemiluminescent analyzerflow cytometernucleic acid extractorclinical diagnosticslab equipmentpoint-of-care testingPOCTbiomarker testingmedical device manufacturerfluorescence immunoassaylab consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Weimi Bio-Tech Co., Ltd. Comparables

Compare Guangzhou Weimi Bio-Tech Co., Ltd. with similar companies based on industry and business-model similarity.

Guangzhou Weimi Bio-Tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zybio Inc.
83%
Wellgrow Technology
82%
Getein Biotech Inc
79%

Guangzhou Weimi Bio-Tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 1, 2021
Series ANov 1, 2018

Guangzhou Weimi Bio-Tech Co., Ltd. Investors

Notable investors and investment history

Guangzhou Weimi Bio-Tech Co., Ltd. investors
InvestorRounds
CCIC CapitalSeries B
Qianshan Capital Management Co., Ltd.Series A
Chuangyu InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2021

    $16M round led by CCIC Capital

  • Nov 1, 2018

    Raised Series A round with Qianshan Capital Management Co., Ltd. as an investor.

Guangzhou Weimi Bio-Tech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Guangzhou Weimi Bio-Tech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangzhou Weimi Bio-Tech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Year Founded2013
Last FundingOct 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?